TRCT
CHE icon

Tower Research Capital (TRC)’s Chemed CHE Stock Holding History

Tower Research Capital (TRC)’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$189K Sell
501
-136
-21% -$58.2K ﹤0.01% 1667
2025
Q4 		$273K Sell
637
-254
-29% -$111K 0.01% 1220
2025
Q3 		$399K Buy
891
+584
+190% +$264K 0.01% 1009
2025
Q2 		$149K Sell
307
-644
-68% -$367K ﹤0.01% 2052
2025
Q1 		$585K Sell
951
-390
-29% -$222K 0.02% 745
2024
Q4 		$710K Sell
1,341
-335
-20% -$189K 0.01% 841
2024
Q3 		$1.01M Buy
1,676
+1,407
+523% +$798K 0.03% 532
2024
Q2 		$146K Sell
269
-724
-73% -$415K ﹤0.01% 2310
2024
Q1 		$637K Buy
993
+83
+9% +$50.4K 0.02% 732
2023
Q4 		$532K Sell
910
-146
-14% -$81.7K 0.01% 1321
2023
Q3 		$549K Sell
1,056
-567
-35% -$295K 0.02% 820
2023
Q2 		$879K Buy
1,623
+1,171
+259% +$640K 0.03% 593
2023
Q1 		$243K Sell
452
-53
-10% -$27K 0.01% 1254
2022
Q4 		$258K Sell
505
-229
-31% -$111K 0.01% 1129
2022
Q3 		$320K Sell
734
-1,169
-61% -$562K 0.01% 1493
2022
Q2 		$893K Sell
1,903
-59
-3% -$28.8K 0.02% 765
2022
Q1 		$994K Sell
1,962
-288
-13% -$138K 0.01% 790
2021
Q4 		$1.19M Buy
2,250
+1,468
+188% +$705K 0.02% 613
2021
Q3 		$364K Sell
782
-1,306
-63% -$616K 0.01% 1222
2021
Q2 		$990K Buy
2,088
+1,327
+174% +$637K 0.03% 663
2021
Q1 		$350K Sell
761
-4,829
-86% -$2.37M 0.01% 1535
2020
Q4 		$2.98M Sell
5,590
-3,043
-35% -$1.5M 0.09% 145
2020
Q3 		$4.15M Sell
8,633
-2,639
-23% -$1.29M 0.05% 111
2020
Q2 		$5.08M Buy
11,272
+11,142
+8,571% +$4.97M 0.21% 69
2020
Q1 		$57K Buy
130
+101
+348% +$45.1K ﹤0.01% 1234
2019
Q4 		$13K Sell
29
-76
-72% -$32K ﹤0.01% 2188
2019
Q3 		$44K Sell
105
-631
-86% -$258K ﹤0.01% 1881
2019
Q2 		$265K Sell
736
-60
-8% -$20.1K 0.02% 737
2019
Q1 		$255K Buy
796
+714
+871% +$219K 0.02% 1022
2018
Q4 		$23K Sell
82
-2,112
-96% -$637K ﹤0.01% 1816
2018
Q3 		$701K Buy
2,194
+1,650
+303% +$526K 0.05% 331
2018
Q2 		$175K Buy
544
+224
+70% +$70.1K 0.01% 1136
2018
Q1 		$87K Sell
320
-3,276
-91% -$868K 0.01% 1352
2017
Q4 		$874K Buy
3,596
+2,446
+213% +$556K 0.11% 187
2017
Q3 		$232K Buy
+1,150
New +$226K 0.02% 663
2016
Q3 		– Sell
-3,441
Closed -$469K – 3705
2016
Q2 		$469K Buy
3,441
+3,431
+34,310% +$455K 0.04% 291
2016
Q1 		$1K Buy
+10
New +$1.35K ﹤0.01% 3652
2015
Q3 		– Sell
-56
Closed -$7K – 4060
2015
Q2 		$7K Sell
56
-1,831
-97% -$227K ﹤0.01% 2981
2015
Q1 		$225K Buy
+1,887
New +$209K 0.03% 359
2014
Q2 		– Sell
-200
Closed -$18K – 4069
2014
Q1 		$18K Sell
200
-302
-60% -$24.6K ﹤0.01% 1987
2013
Q4 		$38K Buy
502
+331
+194% +$24.4K 0.01% 1627
2013
Q3 		$12K Sell
171
-429
-72% -$30.5K ﹤0.01% 3068
2013
Q2 		$43K Buy
+600
New +$44K ﹤0.01% 1052

Other funds holding CHE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Tower Research Capital (TRC)'s CHE Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Chemed (CHE) stake by 21% in Q1 2026, selling an estimated $58.2K and leaving 501 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Tower Research Capital (TRC) first reported a position in CHE in Q2 2013 and has held it in 43 quarters since. The position peaked at $5.08M in Q2 2020. 488 funds tracked by Wall St. Rank hold CHE as of Q1 2026.

  • Tower Research Capital (TRC) held 501 shares of Chemed worth $189K as of Q1 2026.
  • Tower Research Capital (TRC) sold 136 Chemed shares in Q1 2026, an estimated $58.2K.
  • Chemed made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1667 holding.
  • Tower Research Capital (TRC) first reported a position in Chemed in Q2 2013 and has held it in 43 quarters since.
  • Tower Research Capital (TRC)'s Chemed position peaked at $5.08M in Q2 2020.
  • 488 funds tracked by Wall St. Rank held Chemed as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.